Francois Nader

Type: Person
Name: Francois Nader
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

EY​Voice: How One Pharma Company Bounced Back From Failure In A Big Way

When Dr. Francois Nader stepped in as President and CEO of NPS Pharmaceuticals , the company was still reeling from a devastating regulatory setback.The management team had been certain that its lead product in development would soon be approved. In fact, ... [Published Forbes.com - Jul 23 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

NPS Pharmaceuticals reported first-quarter net sales of Gattex totaling $17.9 million, a consensus miss which the company blames on bad winter weather and a rise in the number of patients discontinuing therapy. The slow start to the year means NPS Pharma ... [Published The Street Latest - May 08 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Clementia Pharmaceuticals Inc. Appoints Francois Nader, M.D. to Board of Directors

Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ... [Published Marketwire - Breaking News Releases - Mar 26 2014]

More Content

All (4) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
EY​Voice: How One Pharma Company Bounced Back F... [Published Forbes.com - Jul 23 2014]
NPS Pharma Blames Winter, Drug Stops for Weak F... [Published The Street Latest - May 08 2014]
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
NPS Pharma's hypoparathyroidism drug Natpara ge... [Published PharmaBiz - Jan 07 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clementia Pharmaceuticals Inc. Appoints Francoi... [Published Marketwire - Breaking News Releases - Mar 26 2014]
Healthcare Industry Veteran Brings Deep Expertise in Developing Innovative Therapies for Patients With Rare Diseases ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.